MRGBP (MRG domain binding protein) is a crucial component of multiple chr20-modifying complexes, most notably the NuA4/TIP60 histone acetyltransferase complex, where it facilitates transcriptional regulation through histone H4 and H2A acetylation 12. The protein functions through its ability to interact with diverse chr20-associated complexes via a conserved MRG domain-binding mechanism, forming stable associations with NuA4/TIP60, Sin3B histone deacetylase, ASH1L histone methyltransferase, and PALB2-BRCA2 DNA repair complexes 1. MRGBP also forms a novel TINTIN-like complex with BRD8 and EP400NL that regulates specific gene transcription programs 1. Clinically, MRGBP demonstrates significant oncogenic properties across multiple cancer types, with elevated expression associated with poor prognosis in colorectal cancer, hepatocellular carcinoma, and head and neck squamous cell carcinoma 345. In colorectal cancer specifically, MRGBP promotes metastasis through DKK1/Wnt/β-catenin and NF-κB/p65 pathway-mediated epithelial-mesenchymal transition 6. The protein's expression correlates with immune cell infiltration patterns and serves as both a diagnostic biomarker and potential therapeutic target 34.